Remyelination after spinal cord injury: Is it a target for repair?

Progress in Neurobiology

Volumn 117, Issue , 2014, Pages 54-72

  Plemel, Jason R ^a,b,c,d,e   Keough, Michael B ^b,c,e   Duncan, Greg J ^a,f   Sparling, Joseph S ^a,f   Yong, V Wee ^b,c,e   Stys, Peter K ^b,c   Tetzlaff, Wolfram ^a,g  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d Blusson Spinal Cord Centre   (Canada)

^e The Department of Clinical Neurosciences University of Calgary ^*  (Canada)

^f INTERNATIONAL COLLABORATION ON REPAIR DISCOVERIES   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

Author keywords

Axon degeneration; Myelin; Oligodendrocyte; Oligodendrocyte precursor cell; Remyelination; Spinal cord injury

Indexed keywords

CELL DEATH; CELL TRANSPLANTATION; DEMYELINATION; HUMAN; NERVE FIBER DEGENERATION; OLIGODENDROGLIA; PRIORITY JOURNAL; REMYELINIZATION; REVIEW; SCHWANN CELL; SPINAL CORD INJURY; WHITE MATTER; ANIMAL; DRUG EFFECTS; MYELIN SHEATH; MYELINATED NERVE; PATHOPHYSIOLOGY; PHYSIOLOGY; SPINAL CORD INJURIES;

ANIMALS; HUMANS; MYELIN SHEATH; NERVE FIBERS, MYELINATED; OLIGODENDROGLIA; SCHWANN CELLS; SPINAL CORD INJURIES;

EID: 84900514368     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2014.02.006     Document Type: Review

References (341)

1. Abe Y., Yamamoto T., Sugiyama Y., Watanabe T., Saito N., Kayama H., Kumagai T. Apoptotic cells associated with Wallerian degeneration after experimental spinal cord injury: a possible mechanism of oligodendroglial death. J. Neurotrauma 1999, 16:945-952.
2. Aksenova M., Butterfield D.A., Zhang S.X., Underwood M., Geddes J.W. Increased protein oxidation and decreased creatine kinase BB expression and activity after spinal cord contusion injury. J. Neurotrauma 2002, 19:491-502.
3. Amaral A.I., Meisingset T.W., Kotter M.R., Sonnewald U. Metabolic aspects of neuron-oligodendrocyte-astrocyte interactions. Front. Endocrinol. 2013, 4:54.
4. Andrews E.M., Richards R.J., Yin F.Q., Viapiano M.S., Jakeman L.B. Alterations in chondroitin sulfate proteoglycan expression occur both at and far from the site of spinal contusion injury. Exp. Neurol. 2012, 235:174-187.
5. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., Ting J.P. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 2001, 4:1116-1122.
6. Arnett H.A., Wang Y., Matsushima G.K., Suzuki K., Ting J.P. Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. J. Neurosci. 2003, 23:9824-9832.
7. Arranz A.M., Hussein A., Alix J.J., Perez-Cerda F., Allcock N., Matute C., Fern R. Functional glutamate transport in rodent optic nerve axons and glia. Glia 2008, 56:1353-1367.
8. Arvanian V.L., Schnell L., Lou L., Golshani R., Hunanyan A., Ghosh A., Pearse D.D., Robinson J.K., Schwab M.E., Fawcett J.W., Mendell L.M. Chronic spinal hemisection in rats induces a progressive decline in transmission in uninjured fibers to motoneurons. Exp. Neurol. 2009, 216:471-480.
9. Back S.A., Gan X., Li Y., Rosenberg P.A., Volpe J.J. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J. Neurosci. 1998, 18:6241-6253.
10. Back S.A., Tuohy T.M., Chen H., Wallingford N., Craig A., Struve J., Luo N.L., Banine F., Liu Y., Chang A., Trapp B.D., Bebo B.F., Rao M.S., Sherman L.S. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat. Med. 2005, 11:966-972.
11. Baer A.S., Syed Y.A., Kang S.U., Mitteregger D., Vig R., Ffrench-Constant C., Franklin R.J., Altmann F., Lubec G., Kotter M.R. Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain 2009, 132:465-481.
12. Bai L., Lennon D.P., Caplan A.I., DeChant A., Hecker J., Kranso J., Zaremba A., Miller R.H. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat. Neurosci. 2012, 15:862-870.
13. Bao F., Liu D. Hydroxyl radicals generated in the rat spinal cord at the level produced by impact injury induce cell death by necrosis and apoptosis: protection by a metalloporphyrin. Neuroscience 2004, 126:285-295.
14. Barnabe-Heider F., Goritz C., Sabelstrom H., Takebayashi H., Pfrieger F.W., Meletis K., Frisen J. Origin of new glial cells in intact and injured adult spinal cord. Cell Stem Cell 2010, 7:470-482.
15. Barres B.A., Burne J.F., Holtmann B., Thoenen H., Sendtner M., Raff M.C. Ciliary neurotrophic factor enhances the rate of oligodendrocyte generation. Mol. Cell. Neurosci. 1996, 8:146-156.
16. Barres B.A., Raff M.C. Control of oligodendrocyte number in the developing rat optic nerve. Neuron 1994, 12:935-942.
17. Barres B.A., Schmid R., Sendnter M., Raff M.C. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993, 118:283-295.
18. Beattie M.S., Harrington A.W., Lee R., Kim J.Y., Boyce S.L., Longo F.M., Bresnahan J.C., Hempstead B.L., Yoon S.O. ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 2002, 36:375-386.
19. Ben Abdallah N.M., Slomianka L., Lipp H.P. Reversible effect of X-irradiation on proliferation, neurogenesis, and cell death in the dentate gyrus of adult mice. Hippocampus 2007, 17:1230-1240.
20. Biancotti J.C., Kumar S., de Vellis J. Activation of inflammatory response by a combination of growth factors in cuprizone-induced demyelinated brain leads to myelin repair. Neurochem. Res. 2008, 33:2615-2628.
21. Bieber A.J., Kerr S., Rodriguez M. Efficient central nervous system remyelination requires T cells. Ann. Neurol. 2003, 53:680-684.
22. Biernaskie J., Sparling J.S., Liu J., Shannon C.P., Plemel J.R., Xie Y., Miller F.D., Tetzlaff W. Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury. J. Neurosci. 2007, 27:9545-9559.
23. Blakemore W.F. Pattern of remyelination in the CNS. Nature 1974, 249:577-578.
24. Blakemore W.F., Patterson R.C. Suppression of remyelination in the CNS by X-irradiation. Acta Neuropathol. 1978, 42:105-113.
25. Blight A.R. Axonal physiology of chronic spinal cord injury in the cat: intracellular recording in vitro. Neuroscience 1983, 10:1471-1486.
26. Blight A.R. Cellular morphology of chronic spinal cord injury in the cat: analysis of myelinated axons by line-sampling. Neuroscience 1983, 10:521-543.
27. Blight A.R. Delayed demyelination and macrophage invasion: a candidate for secondary cell damage in spinal cord injury. Cent. Nerv. Syst. Trauma 1985, 2:299-315.
28. Blight A.R. Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury. Brain Res. Bull. 1989, 22:47-52.
29. Bogler O., Wren D., Barnett S.C., Land H., Noble M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc. Natl. Acad. Sci. USA 1990, 87:6368-6372.
30. Boiko T., Rasband M.N., Levinson S.R., Caldwell J.H., Mandel G., Trimmer J.S., Matthews G. Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon. Neuron 2001, 30:91-104.
31. Bostock H., Sears T.A., Sherratt R.M. The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres. J. Physiol. 1981, 313:301-315.
32. Boyd A., Zhang H., Williams A. Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models. Acta Neuropathol. 2013, 125:841-859.
33. Brady S.T., Lasek R.J. Nerve-specific enolase and creatine phosphokinase in axonal transport: soluble proteins and the axoplasmic matrix. Cell 1981, 23:515-523.
34. Bray G.M., Rasminsky M., Aguayo A.J. Interactions between axons and their sheath cells. Annu. Rev. Neurosci. 1981, 4:127-162.
35. Bresnahan J.C., King J.S., Martin G.F., Yashon D. A neuroanatomical analysis of spinal cord injury in the rhesus monkey (Macaca mulatta). J. Neurol. Sci. 1976, 28:521-542.
36. Bretzner F., Plemel J.R., Liu J., Richter M., Roskams A.J., Tetzlaff W. Combination of olfactory ensheathing cells with local versus systemic cAMP treatment after a cervical rubrospinal tract injury. J. Neurosci. Res. 2010, 88:2833-2846.
37. Brown A.M., Baltan Tekkok S., Ransom B.R. Energy transfer from astrocytes to axons: the role of CNS glycogen. Neurochem. Int. 2004, 45:529-536.
38. Brown A.M., Tekkok S.B., Ransom B.R. Glycogen regulation and functional role in mouse white matter. J. Physiol. 2003, 549:501-512.
39. Brown A.M., Wender R., Ransom B.R. Metabolic substrates other than glucose support axon function in central white matter. J. Neurosci. Res. 2001, 66:839-843.
40. Bunge M.B., Bunge R.P., Ris H. Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord. J. Biophys. Biochem. Cytol. 1961, 10:67-94.
41. Bunge R.P. Glial cells and the central myelin sheath. Physiol. Rev. 1968, 48:197-251.
42. Bunge R.P., Puckett W.R., Becerra J.L., Marcillo A., Quencer R.M. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv. Neurol. 1993, 59:75-89.
43. Buss A., Pech K., Merkler D., Kakulas B.A., Martin D., Schoenen J., Noth J., Schwab M.E., Brook G.A. Sequential loss of myelin proteins during Wallerian degeneration in the human spinal cord. Brain 2005, 128:356-364.
44. Buss A., Schwab M.E. Sequential loss of myelin proteins during Wallerian degeneration in the rat spinal cord. Glia 2003, 42:424-432.
45. Butt A.M., Colquhoun K., Berry M. Confocal imaging of glial cells in the intact rat optic nerve. Glia 1994, 10:315-322.
46. Butt A.M., Duncan A., Berry M. Astrocyte associations with nodes of Ranvier: ultrastructural analysis of HRP-filled astrocytes in the mouse optic nerve. J. Neurocytol. 1994, 23:486-499.
47. Canoll P.D., Musacchio J.M., Hardy R., Reynolds R., Marchionni M.A., Salzer J.L. GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron 1996, 17:229-243.
48. Cao Q., Xu X.M., Devries W.H., Enzmann G.U., Ping P., Tsoulfas P., Wood P.M., Bunge M.B., Whittemore S.R. Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J. Neurosci. 2005, 25:6947-6957.
49. Caprariello A.V., Mangla S., Miller R.H., Selkirk S.M. Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination. Ann. Neurol. 2012, 72:395-405.
50. Cardenas D.D., Ditunno J., Graziani V., Jackson A.B., Lammertse D., Potter P., Sipski M., Cohen R., Blight A.R. Phase 2 trial of sustained-release fampridine in chronic spinal cord injury. Spinal Cord 2007, 45:158-168.
51. Casha S., Yu W.R., Fehlings M.G. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 2001, 103:203-218.
52. Cataldo A.M., Broadwell R.D. Cytochemical identification of cerebral glycogen and glucose-6-phosphatase activity under normal and experimental conditions. II. Choroid plexus and ependymal epithelia, endothelia and pericytes. J. Neurocytol. 1986, 15:511-524.
53. Chong S.Y., Rosenberg S.S., Fancy S.P., Zhao C., Shen Y.A., Hahn A.T., McGee A.W., Xu X., Zheng B., Zhang L.I., Rowitch D.H., Franklin R.J., Lu Q.R., Chan J.R. Neurite outgrowth inhibitor Nogo-A establishes spatial segregation and extent of oligodendrocyte myelination. Proc. Natl. Acad. Sci. USA 2012, 109:1299-1304.
54. Connor J.R., Menzies S.L. Relationship of iron to oligodendrocytes and myelination. Glia 1996, 17:83-93.
55. Crowe M.J., Bresnahan J.C., Shuman S.L., Masters J.N., Beattie M.S. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 1997, 3:73-76.
56. Cummings B.J., Uchida N., Tamaki S.J., Salazar D.L., Hooshmand M., Summers R., Gage F.H., Anderson A.J. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc. Natl. Acad. Sci. USA 2005, 102:14069-14074.
57. Curatolo L., Valsasina B., Caccia C., Raimondi G.L., Orsini G., Bianchetti A. Recombinant human IL-2 is cytotoxic to oligodendrocytes after in vitro self aggregation. Cytokine 1997, 9:734-739.
58. Davies J.E., Huang C., Proschel C., Noble M., Mayer-Proschel M., Davies S.J. Astrocytes derived from glial-restricted precursors promote spinal cord repair. J. Biol. 2006, 5:7.
59. Davies J.E., Proschel C., Zhang N., Noble M., Mayer-Proschel M., Davies S.J. Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury. J. Biol. 2008, 7:24.
60. Davies S.J., Shih C.H., Noble M., Mayer-Proschel M., Davies J.E., Proschel C. Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury. PLoS One 2011, 6:e17328.
61. DeForge D., Nymark J., Lemaire E., Gardner S., Hunt M., Martel L., Curran D., Barbeau H. Effect of 4-aminopyridine on gait in ambulatory spinal cord injuries: a double-blind, placebo-controlled, crossover trial. Spinal Cord 2004, 42:674-685.
62. Demopoulos H.B., Flamm E.S., Seligman M.L., Pietronigro D.D., Tomasula J., DeCrescito V. Further studies on free-radical pathology in the major central nervous system disorders: effect of very high doses of methylprednisolone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injury. Can. J. Physiol. Pharmacol. 1982, 60:1415-1424.
63. Diserbo M., Agin A., Lamproglou I., Mauris J., Staali F., Multon E., Amourette C. Blood-brain barrier permeability after gamma whole-body irradiation: an in vivo microdialysis study. Can. J. Physiol. Pharmacol. 2002, 80:670-678.
64. Dringen R., Gebhardt R., Hamprecht B. Glycogen in astrocytes: possible function as lactate supply for neighboring cells. Brain. Res. 1993, 623:208-214.
65. Dringen R., Wiesinger H., Hamprecht B. Uptake of l-lactate by cultured rat brain neurons. Neurosci. Lett. 1993, 163:5-7.
66. Duncan I.D., Brower A., Kondo Y., Curlee J.F., Schultz R.D. Extensive remyelination of the CNS leads to functional recovery. Proc. Natl. Acad. Sci. USA 2009, 106:6832-6836.
67. Duncan I.D., Lunn K.F., Holmgren B., Urba-Holmgren R., Brignolo-Holmes L. The taiep rat: a myelin mutant with an associated oligodendrocyte microtubular defect. J. Neurocytol. 1992, 21:870-884.
68. Eaton J.W., Qian M. Molecular bases of cellular iron toxicity. Free Radic. Biol. Med. 2002, 32:833-840.
69. Eccleston P.A., Silberberg D.H. Fibroblast growth factor is a mitogen for oligodendrocytes in vitro. Brain Res. 1985, 353:315-318.
70. Einstein O., Friedman-Levi Y., Grigoriadis N., Ben-Hur T. Transplanted neural precursors enhance host brain-derived myelin regeneration. J. Neurosci. 2009, 29:15694-15702.
71. Emery E., Aldana P., Bunge M.B., Puckett W., Srinivasan A., Keane R.W., Bethea J., Levi A.D. Apoptosis after traumatic human spinal cord injury. J. Neurosurg. 1998, 89:911-920.
72. England J.D., Gamboni F., Levinson S.R. Increased numbers of sodium channels form along demyelinated axons. Brain Res. 1991, 548:334-337.
73. Fancy S.P., Baranzini S.E., Zhao C., Yuk D.I., Irvine K.A., Kaing S., Sanai N., Franklin R.J., Rowitch D.H. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev. 2009, 23:1571-1585.
74. Fancy S.P., Chan J.R., Baranzini S.E., Franklin R.J., Rowitch D.H. Myelin regeneration: a recapitulation of development?. Annu. Rev. Neurosci. 2011, 34:21-43.
75. Fancy S.P., Harrington E.P., Yuen T.J., Silbereis J.C., Zhao C., Baranzini S.E., Bruce C.C., Otero J.J., Huang E.J., Nusse R., Franklin R.J., Rowitch D.H. Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat. Neurosci. 2011, 14:1009-1016.
76. Faulkner J.R., Herrmann J.E., Woo M.J., Tansey K.E., Doan N.B., Sofroniew M.V. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 2004, 24:2143-2155.
77. Felts P.A., Baker T.A., Smith K.J. Conduction in segmentally demyelinated mammalian central axons. J. Neurosci. 1997, 17:7267-7277.
78. Fern R., Ransom B.R., Waxman S.G. Voltage-gated calcium channels in CNS white matter: role in anoxic injury. J. Neurophysiol. 1995, 74:369-377.
79. Fields R.D., Burnstock G. Purinergic signalling in neuron-glia interactions. Nat. Rev. Neurosci. 2006, 7:423-436.
80. Foote A.K., Blakemore W.F. Inflammation stimulates remyelination in areas of chronic demyelination. Brain 2005, 128:528-539.
81. Foote A.K., Blakemore W.F. Repopulation of oligodendrocyte progenitor cell-depleted tissue in a model of chronic demyelination. Neuropathol. Appl. Neurobiol. 2005, 31:374-383.
82. Fortun J., Hill C.E., Bunge M.B. Combinatorial strategies with Schwann cell transplantation to improve repair of the injured spinal cord. Neurosci. Lett. 2009, 456:124-132.
83. Foster R.E., Whalen C.C., Waxman S.G. Reorganization of the axon membrane in demyelinated peripheral nerve fibers: morphological evidence. Science 1980, 210:661-663.
84. Fouad K., Schnell L., Bunge M.B., Schwab M.E., Liebscher T., Pearse D.D. Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J. Neurosci. 2005, 25:1169-1178.
85. Franklin R.J. Why does remyelination fail in multiple sclerosis?. Nat. Rev. Neurosci. 2002, 3:705-714.
86. Franklin R.J., ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 2008, 9:839-855.
87. Franklin R.J., ffrench-Constant C., Edgar J.M., Smith K.J. Neuroprotection and repair in multiple sclerosis. Nat. Rev. Neurol. 2012, 8:624-634.
88. Funfschilling U., Supplie L.M., Mahad D., Boretius S., Saab A.S., Edgar J., Brinkmann B.G., Kassmann C.M., Tzvetanova I.D., Mobius W., Diaz F., Meijer D., Suter U., Hamprecht B., Sereda M.W., Moraes C.T., Frahm J., Goebbels S., Nave K.A. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 2012, 485:517-521.
89. Germain P., Chambon P., Eichele G., Evans R.M., Lazar M.A., Leid M., De Lera A.R., Lotan R., Mangelsdorf D.J., Gronemeyer H. International Union of Pharmacology. LXIII retinoid X receptors. Pharmacol. Rev. 2006, 58:760-772.
90. Ghasemlou N., Jeong S.Y., Lacroix S., David S. T cells contribute to lysophosphatidylcholine-induced macrophage activation and demyelination in the CNS. Glia 2007, 55:294-302.
91. Ghosh A., Manrique-Hoyos N., Voigt A., Schulz J.B., Kreutzfeldt M., Merkler D., Simons M. Targeted ablation of oligodendrocytes triggers axonal damage. PLoS One 2011, 6:e22735.
92. Gledhill R.F., Harrison B.M., McDonald W.I. Demyelination and remyelination after acute spinal cord compression. Exp. Neurol. 1973, 38:472-487.
93. Gledhill R.F., Harrison B.M., McDonald W.I. Pattern of remyelination in the CNS. Nature 1973, 244:443-444.
94. Gledhill R.F., McDonald W.I. Morphological characteristics of central demyelination and remyelination: a single-fiber study. Ann. Neurol. 1977, 1:552-560.
95. Gregg C., Shikar V., Larsen P., Mak G., Chojnacki A., Yong V.W., Weiss S. White matter plasticity and enhanced remyelination in the maternal CNS. J. Neurosci. 2007, 27:1812-1823.
96. Griffiths I., Klugmann M., Anderson T., Yool D., Thomson C., Schwab M.H., Schneider A., Zimmermann F., McCulloch M., Nadon N., Nave K.A. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 1998, 280:1610-1613.
97. Grijalva I., Guizar-Sahagun G., Castaneda-Hernandez G., Mino D., Maldonado-Julian H., Vidal-Cantu G., Ibarra A., Serra O., Salgado-Ceballos H., Arenas-Hernandez R. Efficacy and safety of 4-aminopyridine in patients with long-term spinal cord injury: a randomized, double-blind, placebo-controlled trial. Pharmacotherapy 2003, 23:823-834.
98. Grossman S.D., Rosenberg L.J., Wrathall J.R. Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion. Exp. Neurol. 2001, 168:273-282.
99. Guest J.D., Hiester E.D., Bunge R.P. Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp. Neurol. 2005, 192:384-393.
100. Guest J.D., Rao A., Olson L., Bunge M.B., Bunge R.P. The ability of human Schwann cell grafts to promote regeneration in the transected nude rat spinal cord. Exp. Neurol. 1997, 148:502-522.
101. Hall E.D. Antioxidant therapies for acute spinal cord injury. Neurotherapeutics 2011, 8:152-167.
102. Hall E.D., Braughler J.M. Effects of intravenous methylprednisolone on spinal cord lipid peroxidation and Na++K+)-ATPase activity. Dose-response analysis during 1st hour after contusion injury in the cat. J Neurosurg 1982, 57:247-253.
103. Hampton D.W., Innes N., Merkler D., Zhao C., Franklin R.J., Chandran S. Focal immune-mediated white matter demyelination reveals an age-associated increase in axonal vulnerability and decreased remyelination efficiency. Am. J. Pathol. 2012.
104. Harris J.J., Attwell D. The energetics of CNS white matter. J. Neurosci. 2012, 32:356-371.
105. Harsan L.A., Steibel J., Zaremba A., Agin A., Sapin R., Poulet P., Guignard B., Parizel N., Grucker D., Boehm N., Miller R.H., Ghandour M.S. Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging. J. Neurosci. 2008, 28:14189-14201.
106. Hawryluk G.W., Mothe A., Wang J., Wang S., Tator C., Fehlings M.G. An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev. 2012, 21:2222-2238.
107. Hawryluk G.W., Spano S., Chew D., Wang S., Erwin M., Chamankhah M., Forgione N., Fehlings M.G. An examination of the mechanisms by which neural precursors augment recovery following spinal cord injury: a key role for remyelination. Cell Transplant. 2013.
108. Hayes K.C., Potter P.J., Wolfe D.L., Hsieh J.T., Delaney G.A., Blight A.R. 4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury. J. Neurotrauma 1994, 11:433-446.
109. Herbert V., Shaw S., Jayatilleke E., Stopler-Kasdan T. Most free-radical injury is iron-related: it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells 1994, 12:289-303.
110. Herrmann J.E., Imura T., Song B., Qi J., Ao Y., Nguyen T.K., Korsak R.A., Takeda K., Akira S., Sofroniew M.V. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci. 2008, 28:7231-7243.
111. Hinks G.L., Chari D.M., O'Leary M.T., Zhao C., Keirstead H.S., Blakemore W.F., Franklin R.J. Depletion of endogenous oligodendrocyte progenitors rather than increased availability of survival factors is a likely explanation for enhanced survival of transplanted oligodendrocyte progenitors in X-irradiated compared to normal CNS. Neuropathol. Appl. Neurobiol. 2001, 27:59-67.
112. Hinks G.L., Franklin R.J. Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats. Mol. Cell. Neurosci. 2000, 16:542-556.
113. Hofstetter C.P., Holmstrom N.A., Lilja J.A., Schweinhardt P., Hao J., Spenger C., Wiesenfeld-Hallin Z., Kurpad S.N., Frisen J., Olson L. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat. Neurosci. 2005, 8:346-353.
114. Horky L.L., Galimi F., Gage F.H., Horner P.J. Fate of endogenous stem/progenitor cells following spinal cord injury. J. Comp. Neurol. 2006, 498:525-538.
115. Huang C., Han X., Li X., Lam E., Peng W., Lou N., Torres A., Yang M., Garre J.M., Tian G.F., Bennett M.V., Nedergaard M., Takano T. Critical role of connexin 43 in secondary expansion of traumatic spinal cord injury. J. Neurosci. 2012, 32:3333-3338.
116. Huang J.K., Jarjour A.A., Nait Oumesmar B., Kerninon C., Williams A., Krezel W., Kagechika H., Bauer J., Zhao C., Evercooren A.B., Chambon P., Ffrench-Constant C., Franklin R.J. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat. Neurosci. 2011, 14:45-53.
117. Huang S.M., Mishina Y.M., Liu S., Cheung A., Stegmeier F., Michaud G.A., Charlat O., Wiellette E., Zhang Y., Wiessner S., Hild M., Shi X., Wilson C.J., Mickanin C., Myer V., Fazal A., Tomlinson R., Serluca F., Shao W., Cheng H., Shultz M., Rau C., Schirle M., Schlegl J., Ghidelli S., Fawell S., Lu C., Curtis D., Kirschner M.W., Lengauer C., Finan P.M., Tallarico J.A., Bouwmeester T., Porter J.A., Bauer A., Cong F. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 2009, 461:614-620.
118. Hughes E.G., Kang S.H., Fukaya M., Bergles D.E. Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain. Nat. Neurosci. 2013.
119. Hunanyan A.S., Garcia-Alias G., Alessi V., Levine J.M., Fawcett J.W., Mendell L.M., Arvanian V.L. Role of chondroitin sulfate proteoglycans in axonal conduction in Mammalian spinal cord. J. Neurosci. 2010, 30:7761-7769.
120. Husain J., Juurlink B.H. Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species. Brain Res. 1995, 698:86-94.
121. Irvine K.A., Blakemore W.F. Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice. J. Neuroimmunol. 2006, 175:69-76.
122. Irvine K.A., Blakemore W.F. Remyelination protects axons from demyelination-associated axon degeneration. Brain 2008, 131:1464-1477.
123. Itoyama Y., Webster H.D., Richardson E.P., Trapp B.D. Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions. Ann. Neurol. 1983, 14:339-346.
124. James N.D., Bartus K., Grist J., Bennett D.L., McMahon S.B., Bradbury E.J. Conduction failure following spinal cord injury: functional and anatomical changes from acute to chronic stages. J. Neurosci. 2011, 31:18543-18555.
125. Jeffery N.D., Blakemore W.F. Remyelination of mouse spinal cord axons demyelinated by local injection of lysolecithin. J. Neurocytol. 1995, 24:775-781.
126. Jeffery N.D., Blakemore W.F. Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination. Brain 1997, 120(Pt 1):27-37.
127. Jensen A.L., Durand D.M. High frequency stimulation can block axonal conduction. Exp. Neurol. 2009, 220:57-70.
128. Jho E.H., Zhang T., Domon C., Joo C.K., Freund J.N., Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 2002, 22:1172-1183.
129. Ji B., Li M., Wu W.T., Yick L.W., Lee X., Shao Z., Wang J., So K.F., McCoy J.M., Pepinsky R.B., Mi S., Relton J.K. LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury. Mol. Cell. Neurosci. 2006, 33:311-320.
130. Jia Z., Zhu H., Li J., Wang X., Misra H., Li Y. Oxidative stress in spinal cord injury and antioxidant-based intervention. Spinal Cord 2012, 50:264-274.
131. Jiang D., Liang J., Noble P.W. Hyaluronan as an immune regulator in human diseases. Physiol. Rev. 2011, 91:221-264.
132. Jones R.E., Heron J.R., Foster D.H., Snelgar R.S., Mason R.J. Effects of 4-aminopyridine in patients with multiple sclerosis. J. Neurol. Sci. 1983, 60:353-362.
133. Juurlink B.H., Thorburne S.K., Hertz L. Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress. Glia 1998, 22:371-378.
134. Kakulas B.A. A review of the neuropathology of human spinal cord injury with emphasis on special features. J. Spinal Cord Med. 1999, 22:119-124.
135. Kaneko S., Iwanami A., Nakamura M., Kishino A., Kikuchi K., Shibata S., Okano H.J., Ikegami T., Moriya A., Konishi O., Nakayama C., Kumagai K., Kimura T., Sato Y., Goshima Y., Taniguchi M., Ito M., He Z., Toyama Y., Okano H. A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat. Med. 2006, 12:1380-1389.
136. Kang S.H., Fukaya M., Yang J.K., Rothstein J.D., Bergles D.E. NG2+CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration. Neuron 2010, 68:668-681.
137. Kang Z., Wang C., Zepp J., Wu L., Sun K., Zhao J., Chandrasekharan U., DiCorleto P.E., Trapp B.D., Ransohoff R.M., Li X. Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2(+) glial cells. Nat. Neurosci. 2013, 16:1401-1408.
138. Kanno H., Ozawa H., Sekiguchi A., Itoi E. Spinal cord injury induces upregulation of Beclin 1 and promotes autophagic cell death. Neurobiol. Dis. 2009, 33:143-148.
139. Kanno H., Ozawa H., Sekiguchi A., Yamaya S., Itoi E. Induction of autophagy and autophagic cell death in damaged neural tissue after acute spinal cord injury in mice. Spine (Phila Pa 1976) 2011, 36:E1427-E1434.
140. Kaplan M.R., Cho M.H., Ullian E.M., Isom L.L., Levinson S.R., Barres B.A. Differential control of clustering of the sodium channels Na(v)1.2 and Na(v)1.6 at developing CNS nodes of Ranvier. Neuron 2001, 30:105-119.
141. Karadottir R., Cavelier P., Bergersen L.H., Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005, 438:1162-1166.
142. Karimi-Abdolrezaee S., Eftekharpour E. Stem cells and spinal cord injury repair. Adv. Exp. Med. Biol. 2012, 760:53-73.
143. Karimi-Abdolrezaee S., Eftekharpour E., Wang J., Morshead C.M., Fehlings M.G. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J. Neurosci. 2006, 26:3377-3389.
144. Keirstead H.S. Stem cells for the treatment of myelin loss. Trends Neurosci. 2005, 28:677-683.
145. Keirstead H.S., Blakemore W.F. Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J. Neuropathol. Exp. Neurol. 1997, 56:1191-1201.
146. Kiryu-Seo S., Ohno N., Kidd G.J., Komuro H., Trapp B.D. Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport. J. Neurosci. 2010, 30(19):6658-6666.
147. Keirstead H.S., Nistor G., Bernal G., Totoiu M., Cloutier F., Sharp K., Steward O. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. 2005, 25:4694-4705.
148. Keough M.B., Yong V.W. Remyelination therapy for multiple sclerosis. Neurotherapeutics 2013, 10:44-54.
149. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 2009, 29:13435-13444.
150. Koshinaga M., Sanon H.R., Whittemore S.R. Altered acidic and basic fibroblast growth factor expression following spinal cord injury. Exp. Neurol. 1993, 120:32-48.
151. Kotter M.R., Li W.W., Zhao C., Franklin R.J. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J. Neurosci. 2006, 26:328-332.
152. Kotter M.R., Setzu A., Sim F.J., Van Rooijen N., Franklin R.J. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 2001, 35:204-212.
153. Kotter M.R., Zhao C., van Rooijen N., Franklin R.J. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol. Dis. 2005, 18:166-175.
154. Kwon B.K., Oxland T.R., Tetzlaff W. Animal models used in spinal cord regeneration research. Spine 2002, 27:1504-1510.
155. Kwon B.K., Stammers A.M., Belanger L.M., Bernardo A., Chan D., Bishop C.M., Slobogean G.P., Zhang H., Umedaly H., Giffin M., Street J., Boyd M.C., Paquette S.J., Fisher C.G., Dvorak M.F. Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury. J. Neurotrauma. 2010, 27:669-682.
156. Kwon B.K., Tetzlaff W., Grauer J.N., Beiner J., Vaccaro A.R. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J. 2004, 4:451-464.
157. Lacroix S., Hamilton L.K., Vaugeois A., Beaudoin S., Breault-Dugas C., Pineau I., Levesque S.A., Gregoire C.A., Fernandes K.J. Central canal ependymal cells proliferate extensively in response to traumatic spinal cord injury but not demyelinating lesions. PLoS One 2014, 9:e85916.
158. Lappe-Siefke C., Goebbels S., Gravel M., Nicksch E., Lee J., Braun P.E., Griffiths I.R., Nave K.A. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet. 2003, 33:366-374.
159. Lasiene J., Shupe L., Perlmutter S., Horner P. No evidence for chronic demyelination in spared axons after spinal cord injury in a mouse. J. Neurosci. 2008, 28:3887-3896.
160. Lau L.W., Cua R., Keough M.B., Haylock-Jacobs S., Yong V.W. Pathophysiology of the brain extracellular matrix: a new target for remyelination. Nat. Rev. Neurosci. 2013, 14:722-729.
161. Lau L.W., Keough M.B., Haylock-Jacobs S., Cua R., Doring A., Sloka S., Stirling D.P., Rivest S., Yong V.W. Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination. Ann. Neurol. 2012, 72:419-432.
162. Lee K.H., Yoon do H., Park Y.G., Lee B.H. Effects of glial transplantation on functional recovery following acute spinal cord injury. J. Neurotrauma 2005, 22:575-589.
163. Lee X., Yang Z., Shao Z., Rosenberg S.S., Levesque M., Pepinsky R.B., Qiu M., Miller R.H., Chan J.R., Mi S. NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination. J. Neurosci. 2007, 27:220-225.
164. Lee Y., Morrison B.M., Li Y., Lengacher S., Farah M.H., Hoffman P.N., Liu Y., Tsingalia A., Jin L., Zhang P.W., Pellerin L., Magistretti P.J., Rothstein J.D. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 2012, 487:443-448.
165. Levine J.M., Reynolds R. Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination. Exp. Neurol. 1999, 160:333-347.
166. Li G.L., Brodin G., Farooque M., Funa K., Holtz A., Wang W.L., Olsson Y. Apoptosis and expression of Bcl-2 after compression trauma to rat spinal cord. J. Neuropathol. Exp. Neurol. 1996, 55:280-289.
167. Li G.L., Farooque M., Holtz A., Olsson Y. Apoptosis of oligodendrocytes occurs for long distances away from the primary injury after compression trauma to rat spinal cord. Acta Neuropathol. 1999, 98:473-480.
168. Li J., Ramenaden E.R., Peng J., Koito H., Volpe J.J., Rosenberg P.A. Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present. J. Neurosci. 2008, 28:5321-5330.
169. Li S., Stys P.K. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J. Neurosci. 2000, 20:1190-1198.
170. Li S., Stys P.K. Na(+)-K(+)-ATPase inhibition and depolarization induce glutamate release via reverse Na(+)-dependent transport in spinal cord white matter. Neuroscience 2001, 107:675-683.
171. Li W.W., Setzu A., Zhao C., Franklin R.J. Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J. Neuroimmunol. 2005, 158:58-66.
172. Li Y.Q., Chen P., Jain V., Reilly R.M., Wong C.S. Early radiation-induced endothelial cell loss and blood-spinal cord barrier breakdown in the rat spinal cord. Radiat. Res. 2004, 161:143-152.
173. Liebetanz D., Merkler D. Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis. Exp. Neurol. 2006, 202:217-224.
174. Liu D., Bao F., Prough D.S., Dewitt D.S. Peroxynitrite generated at the level produced by spinal cord injury induces peroxidation of membrane phospholipids in normal rat cord: reduction by a metalloporphyrin. J. Neurotrauma 2005, 22:1123-1133.
175. Liu D., Ling X., Wen J., Liu J. The role of reactive nitrogen species in secondary spinal cord injury: formation of nitric oxide, peroxynitrite, and nitrated protein. J. Neurochem. 2000, 75:2144-2154.
176. Liu D., Liu J., Sun D., Wen J. The time course of hydroxyl radical formation following spinal cord injury: the possible role of the iron-catalyzed Haber-Weiss reaction. J. Neurotrauma 2004, 21:805-816.
177. Liu D., Sybert T.E., Qian H., Liu J. Superoxide production after spinal injury detected by microperfusion of cytochrome c. Free Radic. Biol. Med. 1998, 25:298-304.
178. Liu X.Z., Xu X.M., Hu R., Du C., Zhang S.X., McDonald J.W., Dong H.X., Wu Y.J., Fan G.S., Jacquin M.F., Hsu C.Y., Choi D.W. Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 1997, 17:5395-5406.
179. Liu Y., Wang X., Lu C.C., Kerman R., Steward O., Xu X.M., Zou Y. Repulsive Wnt signaling inhibits axon regeneration after CNS injury. J. Neurosci. 2008, 28(33):8376-8382.
180. Locatelli G., Wortge S., Buch T., Ingold B., Frommer F., Sobottka B., Kruger M., Karram K., Buhlmann C., Bechmann I., Heppner F.L., Waisman A., Becher B. Primary oligodendrocyte death does not elicit anti-CNS immunity. Nat. Neurosci. 2012, 15:543-550.
181. Loers G., Aboul-Enein F., Bartsch U., Lassmann H., Schachner M. Comparison of myelin, axon, lipid, and immunopathology in the central nervous system of differentially myelin-compromised mutant mice: a morphological and biochemical study. Mol. Cell Neurosci. 2004, 27:175-189.
182. Ludwin S.K. Chronic demyelination inhibits remyelination in the central nervous system. An analysis of contributing factors. Lab Invest. 1980, 43:382-387.
183. Lustig B., Jerchow B., Sachs M., Weiler S., Pietsch T., Karsten U., van de Wetering M., Clevers H., Schlag P.M., Birchmeier W., Behrens J. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol. Cell Biol. 2002, 22:1184-1193.
184. Lytle J.M., Chittajallu R., Wrathall J.R., Gallo V. NG2 cell response in the CNP-EGFP mouse after contusive spinal cord injury. Glia 2009, 57:270-285.
185. Lytle J.M., Wrathall J.R. Glial cell loss, proliferation and replacement in the contused murine spinal cord. Eur. J. Neurosci. 2007, 25:1711-1724.
186. Marret S., Delpech B., Delpech A., Asou H., Girard N., Courel M.N., Chauzy C., Maingonnat C., Fessard C. Expression and effects of hyaluronan and of the hyaluronan-binding protein hyaluronectin in newborn rat brain glial cell cultures. J. Neurochem. 1994, 62:1285-1295.
187. Martin D., Schoenen J., Delree P., Leprince P., Rogister B., Moonen G. Grafts of syngenic cultured, adult dorsal root ganglion-derived Schwann cells to the injured spinal cord of adult rats: preliminary morphological studies. Neurosci. Lett. 1991, 124:44-48.
188. Mason J.L., Suzuki K., Chaplin D.D., Matsushima G.K. Interleukin-1beta promotes repair of the CNS. J. Neurosci. 2001, 21:7046-7052.
189. Matute C., Sanchez-Gomez M.V., Martinez-Millan L., Miledi R. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc. Natl. Acad. Sci. USA 1997, 94:8830-8835.
190. Matute C., Torre I., Perez-Cerda F., Perez-Samartin A., Alberdi E., Etxebarria E., Arranz A.M., Ravid R., Rodriguez-Antiguedad A., Sanchez-Gomez M., Domercq M. P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J. Neurosci. 2007, 27:9525-9533.
191. McAdoo D.J., Hughes M.G., Xu G.Y., Robak G., de Castro R. Microdialysis studies of the role of chemical agents in secondary damage upon spinal cord injury. J. Neurotrauma 1997, 14:507-515.
192. McAdoo D.J., Wu P. Microdialysis in central nervous system disorders and their treatment. Pharmacol. Biochem. Behav. 2008, 90:282-296.
193. McDonald J.W., Althomsons S.P., Hyrc K.L., Choi D.W., Goldberg M.P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat. Med. 1998, 4:291-297.
194. McMorris F.A., Dubois-Dalcq M. Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro. J. Neurosci. Res. 1988, 21:199-209.
195. McTigue D.M., Horner P.J., Stokes B.T., Gage F.H. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J. Neurosci. 1998, 18:5354-5365.
196. McTigue D.M., Tripathi R.B. The life, death, and replacement of oligodendrocytes in the adult CNS. J. Neurochem. 2008, 107:1-19.
197. McTigue D.M., Wei P., Stokes B.T. Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. J. Neurosci. 2001, 21:3392-3400.
198. Meletis K., Barnabe-Heider F., Carlen M., Evergren E., Tomilin N., Shupliakov O., Frisen J. Spinal cord injury reveals multilineage differentiation of ependymal cells. PLoS Biol. 2008, 6:e182.
199. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 1993, 151:2132-2141.
200. Mi S., Hu B., Hahm K., Luo Y., Kam Hui E.S., Yuan Q., Wong W.M., Wang L., Su H., Chu T.H., Guo J., Zhang W., So K.F., Pepinsky B., Shao Z., Graff C., Garber E., Jung V., Wu E.X., Wu W. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat. Med. 2007, 13:1228-1233.
201. Mi S., Lee X., Shao Z., Thill G., Ji B., Relton J., Levesque M., Allaire N., Perrin S., Sands B., Crowell T., Cate R.L., McCoy J.M., Pepinsky R.B. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat. Neurosci. 2004, 7:221-228.
202. Mi S., Miller R.H., Lee X., Scott M.L., Shulag-Morskaya S., Shao Z., Chang J., Thill G., Levesque M., Zhang M., Hession C., Sah D., Trapp B., He Z., Jung V., McCoy J.M., Pepinsky R.B. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat. Neurosci. 2005, 8:745-751.
203. Mi S., Miller R.H., Tang W., Lee X., Hu B., Wu W., Zhang Y., Shields C.B., Miklasz S., Shea D., Mason J., Franklin R.J., Ji B., Shao Z., Chedotal A., Bernard F., Roulois A., Xu J., Jung V., Pepinsky B. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann. Neurol. 2009, 65:304-315.
204. Micu I., Jiang Q., Coderre E., Ridsdale A., Zhang L., Woulfe J., Yin X., Trapp B.D., McRory J.E., Rehak R., Zamponi G.W., Wang W., Stys P.K. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 2006, 439:988-992.
205. Milvy P., Kakari S., Campbell J.B., Demopoulos H.B. Paramagnetic species and radical products in cat spinal cord. Ann. N Y Acad. Sci. 1973, 222:1102-1111.
206. Miron V.E., Boyd A., Zhao J.W., Yuen T.J., Ruckh J.M., Shadrach J.L., van Wijngaarden P., Wagers A.J., Williams A., Franklin R.J., Ffrench-Constant C. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 2013, 16:1211-1218.
207. Mitsui T., Shumsky J.S., Lepore A.C., Murray M., Fischer I. Transplantation of neuronal and glial restricted precursors into contused spinal cord improves bladder and motor functions, decreases thermal hypersensitivity, and modifies intraspinal circuitry. J. Neurosci. 2005, 25:9624-9636.
208. Mocchetti I., Rabin S.J., Colangelo A.M., Whittemore S.R., Wrathall J.R. Increased basic fibroblast growth factor expression following contusive spinal cord injury. Exp. Neurol. 1996, 141:154-164.
209. Morell P., Barrett C.V., Mason J.L., Toews A.D., Hostettler J.D., Knapp G.W., Matsushima G.K. Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol. Cell Neurosci. 1998, 12:220-227.
210. Nave K.A. Myelination and support of axonal integrity by glia. Nature 2010, 468:244-252.
211. Nave K.A. Myelination and the trophic support of long axons. Nat. Rev. Neurosci. 2010, 11:275-283.
212. Nave K.A., Trapp B.D. Axon-glial signaling and the glial support of axon function. Annu. Rev. Neurosci. 2008, 31:535-561.
213. Nguyen T., Mehta N.R., Conant K., Kim K.J., Jones M., Calabresi P.A., Melli G., Hoke A., Schnaar R.L., Ming G.L., Song H., Keswani S.C., Griffin J.W. Axonal protective effects of the myelin-associated glycoprotein. J. Neurosci. 2009, 29:630-637.
214. Nikolaeva M.A., Richard S., Mouihate A., Stys P.K. Effects of the noradrenergic system in rat white matter exposed to oxygen-glucose deprivation in vitro. J. Neurosci. 2009, 29:1796-1804.
215. Noble P.G., Antel J.P., Yong V.W. Astrocytes and catalase prevent the toxicity of catecholamines to oligodendrocytes. Brain Res. 1994, 633:83-90.
216. Norenberg M.D., Smith J., Marcillo A. The pathology of human spinal cord injury: defining the problems. J. Neurotrauma 2004, 21:429-440.
217. Novakovic S.D., Levinson S.R., Schachner M., Shrager P. Disruption and reorganization of sodium channels in experimental allergic neuritis. Muscle Nerve 1998, 21:1019-1032.
218. Oblinger M.M., Foe L.G., Kwiatkowska D., Kemp R.G. Phosphofructokinase in the rat nervous system: regional differences in activity and characteristics of axonal transport. J. Neurosci. Res. 1988, 21:25-34.
219. Oka A., Belliveau M.J., Rosenberg P.A., Volpe J.J. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J. Neurosci. 1993, 13:1441-1453.
220. Okada S., Nakamura M., Katoh H., Miyao T., Shimazaki T., Ishii K., Yamane J., Yoshimura A., Iwamoto Y., Toyama Y., Okano H. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat. Med. 2006, 12:829-834.
221. Oluich L.J., Stratton J.A., Xing Y.L., Ng S.W., Cate H.S., Sah P., Windels F., Kilpatrick T.J., Merson T.D. Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination. J. Neurosci. 2012, 32:8317-8330.
222. Ouardouz M., Coderre E., Basak A., Chen A., Zamponi G.W., Hameed S., Rehak R., Yin X., Trapp B.D., Stys P.K. Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors. Ann. Neurol. 2009, 65:151-159.
223. Ouardouz M., Coderre E., Zamponi G.W., Hameed S., Yin X., Trapp B.D., Stys P.K. Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors. Ann. Neurol. 2009, 65:160-166.
224. 2+ channel activation of ryanodine receptors. Neuron 2003, 40:53-63.
225. Ousman S.S., David S. Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 2000, 30:92-104.
226. Pantoni L., Garcia J.H., Gutierrez J.A. Cerebral white matter is highly vulnerable to ischemia. Stroke 1996, 27:1641-1646. discussion 1647.
227. Parr A.M., Kulbatski I., Zahir T., Wang X., Yue C., Keating A., Tator C.H. Transplanted adult spinal cord-derived neural stem/progenitor cells promote early functional recovery after rat spinal cord injury. Neuroscience 2008, 155:760-770.
228. Peng W., Cotrina M.L., Han X., Yu H., Bekar L., Blum L., Takano T., Tian G.F., Goldman S.A., Nedergaard M. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc. Natl. Acad. Sci. USA 2009, 106:12489-12493.
229. Petrosyan H.A., Hunanyan A.S., Alessi V., Schnell L., Levine J., Arvanian V.L. Neutralization of inhibitory molecule NG2 improves synaptic transmission, retrograde transport, and locomotor function after spinal cord injury in adult rats. J. Neurosci. 2013, 33:4032-4043.
230. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J. Neurol. Sci. 2005, 233:183-198.
231. Piaton G., Aigrot M.S., Williams A., Moyon S., Tepavcevic V., Moutkine I., Gras J., Matho K.S., Schmitt A., Soellner H., Huber A.B., Ravassard P., Lubetzki C. Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system. Brain 2011, 134:1156-1167.
232. Plant S.R., Iocca H.A., Wang Y., Thrash J.C., O'Connor B.P., Arnett H.A., Fu Y.X., Carson M.J., Ting J.P. Lymphotoxin beta receptor (Lt betaR): dual roles in demyelination and remyelination and successful therapeutic intervention using Lt betaR-Ig protein. J. Neurosci. 2007, 27:7429-7437.
233. Plemel J.R., Chojnacki A., Sparling J.S., Liu J., Plunet W., Duncan G.J., Park S.E., Weiss S., Tetzlaff W. Platelet-derived growth factor-responsive neural precursors give rise to myelinating oligodendrocytes after transplantation into the spinal cords of contused rats and dysmyelinated mice. Glia 2011, 59:1891-1910.
234. Plemel J.R., Duncan G., Chen K.W., Shannon C., Park S., Sparling J.S., Tetzlaff W. A graded forceps crush spinal cord injury model in mice. J. Neurotrauma 2008, 25:350-370.
235. Plemel J.R., Manesh S.B., Sparling J.S., Tetzlaff W. Myelin Inhibits Oligodendroglial Maturation and Regulates Oligodendrocytic Transcription Factor Expression 2013, Glia.
236. Pluchino S., Quattrini A., Brambilla E., Gritti A., Salani G., Dina G., Galli R., Del Carro U., Amadio S., Bergami A., Furlan R., Comi G., Vescovi A.L., Martino G. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003, 422:688-694.
237. Pluchino S., Zanotti L., Rossi B., Brambilla E., Ottoboni L., Salani G., Martinello M., Cattalini A., Bergami A., Furlan R., Comi G., Constantin G., Martino G. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005, 436:266-271.
238. Pohl H.B., Porcheri C., Mueggler T., Bachmann L.C., Martino G., Riethmacher D., Franklin R.J., Rudin M., Suter U. Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. J. Neurosci. 2011, 31:1069-1080.
239. Pollack, A. (2011) Geron is shutting down its stem cell clinical trial. In: The New York Times. p. B2.
240. Potter P.J., Hayes K.C., Segal J.L., Hsieh J.T., Brunnemann S.R., Delaney G.A., Tierney D.S., Mason D. Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injury. J. Neurotrauma 1998, 15:837-849.
241. Powers B.E., Lasiene J., Plemel J.R., Shupe L., Perlmutter S.I., Tetzlaff W., Horner P.J. Axonal thinning and extensive remyelination without chronic demyelination in spinal injured rats. J. Neurosci. 2012, 32:5120-5125.
242. Powers B.E., Sellers D.L., Lovelett E.A., Cheung W., Aalami S.P., Zapertov N., Maris D.O., Horner P.J. Remyelination reporter reveals prolonged refinement of spontaneously regenerated myelin. Proc. Natl. Acad. Sci. USA 2013, 110:4075-4080.
243. Psachoulia K., Jamen F., Young K.M., Richardson W.D. Cell cycle dynamics of NG2 cells in the postnatal and ageing brain. Neuron Glia Biol. 2009, 5:57-67.
244. Puttagunta R., Di Giovanni S. Retinoic acid signaling in axonal regeneration. Front. Mol. Neurosci. 2011, 4:59.
245. Qian H., Liu D. The time course of malondialdehyde production following impact injury to rat spinal cord as measured by microdialysis and high pressure liquid chromatography. Neurochem. Res. 1997, 22:1231-1236.
246. Qiao J., Hayes K.C., Hsieh J.T., Potter P.J., Delaney G.A. Effects of 4-aminopyridine on motor evoked potentials in patients with spinal cord injury. J. Neurotrauma 1997, 14:135-149.
247. Ramer L.M., Au E., Richter M.W., Liu J., Tetzlaff W., Roskams A.J. Peripheral olfactory ensheathing cells reduce scar and cavity formation and promote regeneration after spinal cord injury. J. Comp. Neurol. 2004, 473:1-15.
248. Ramer L.M., Richter M.W., Roskams A.J., Tetzlaff W., Ramer M.S. Peripherally-derived olfactory ensheathing cells do not promote primary afferent regeneration following dorsal root injury. Glia 2004, 47:189-206.
249. Rathore K.I., Kerr B.J., Redensek A., Lopez-Vales R., Jeong S.Y., Ponka P., David S. Ceruloplasmin protects injured spinal cord from iron-mediated oxidative damage. J. Neurosci. 2008, 28:12736-12747.
250. Redford E.J., Kapoor R., Smith K.J. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 1997, 120(Pt 12):2149-2157.
251. Richter M.W., Roskams A.J. Olfactory ensheathing cell transplantation following spinal cord injury: hype or hope?. Exp. Neurol. 2008, 209:353-367.
252. Rinholm J.E., Hamilton N.B., Kessaris N., Richardson W.D., Bergersen L.H., Attwell D. Regulation of oligodendrocyte development and myelination by glucose and lactate. J. Neurosci. 2011, 31:538-548.
253. Ritchie J.M., Rogart R.B. Density of sodium channels in mammalian myelinated nerve fibers and nature of the axonal membrane under the myelin sheath. Proc. Natl. Acad. Sci. USA 1977, 74:211-215.
254. Rivers L.E., Young K.M., Rizzi M., Jamen F., Psachoulia K., Wade A., Kessaris N., Richardson W.D. PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nat. Neurosci. 2008, 11:1392-1401.
255. Robinson S., Miller R.H. Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation. Dev. Biol. 1999, 216:359-368.
256. Ruckh J.M., Zhao J.W., Shadrach J.L., van Wijngaarden P., Rao T.N., Wagers A.J., Franklin R.J. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 2012, 10:96-103.
257. Salter M.G., Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 2005, 438:1167-1171.
258. Sasaki M., Lankford K.L., Radtke C., Honmou O., Kocsis J.D. Remyelination after olfactory ensheathing cell transplantation into diverse demyelinating environments. Exp. Neurol. 2011, 229:88-98.
259. Scheibner K.A., Lutz M.A., Boodoo S., Fenton M.J., Powell J.D., Horton M.R. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 2006, 177:1272-1281.
260. Schilling T., Eder C. Importance of lipid rafts for lysophosphatidylcholine-induced caspase-1 activation and reactive oxygen species generation. Cell Immunol. 2010, 265:87-90.
261. Schilling T., Eder C. Sodium dependence of lysophosphatidylcholine-induced caspase-1 activity and reactive oxygen species generation. Immunobiology 2011, 216:118-125.
262. Schulz K., Vulpe C.D., Harris L.Z., David S. Iron efflux from oligodendrocytes is differentially regulated in gray and white matter. J. Neurosci. 2011, 31:13301-13311.
263. Scott G.S., Jakeman L.B., Stokes B.T., Szabo C. Peroxynitrite production and activation of poly (adenosine diphosphate-ribose) synthetase in spinal cord injury. Ann. Neurol. 1999, 45:120-124.
264. Segal J.L., Pathak M.S., Hernandez J.P., Himber P.L., Brunnemann S.R., Charter R.S. Safety and efficacy of 4-aminopyridine in humans with spinal cord injury: a long-term, controlled trial. Pharmacotherapy 1999, 19:713-723.
265. Seligman M.L., Flamm E.S., Goldstein B.D., Poser R.G., Demopoulos H.B., Ransohoff J. Spectrofluorescent detection of malonaldehyde as a measure of lipid free radical damage in response to ethanol potentiation of spinal cord trauma. Lipids 1977, 12:945-950.
266. Seth P., Koul N. Astrocyte, the star avatar: redefined. J. Biosci. 2008, 33:405-421.
267. Sharma K., Selzer M.E., Li S. Scar-mediated inhibition and CSPG receptors in the CNS. Exp. Neurol. 2012, 237:370-378.
268. Sharp J., Frame J., Siegenthaler M., Nistor G., Keirstead H.S. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells 2010, 28:152-163.
269. Sheikh A.M., Nagai A., Ryu J.K., McLarnon J.G., Kim S.U., Masuda J. Lysophosphatidylcholine induces glial cell activation: role of rho kinase. Glia 2009, 57:898-907.
270. Sherratt R.M., Bostock H., Sears T.A. Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres. Nature 1980, 283:570-572.
271. Sherwin C., Fern R. Acute lipopolysaccharide-mediated injury in neonatal white matter glia: role of TNF-alpha, IL-1beta, and calcium. J. Immunol. 2005, 175:155-161.
272. Shi J., Marinovich A., Barres B.A. Purification and characterization of adult oligodendrocyte precursor cells from the rat optic nerve. J. Neurosci. 1998, 18:4627-4636.
273. Shi Y., Sun W., McBride J.J., Cheng J.X., Shi R. Acrolein induces myelin damage in mammalian spinal cord. J. Neurochem. 2011, 117:554-564.
274. Shields S.A., Gilson J.M., Blakemore W.F., Franklin R.J. Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination. Glia 1999, 28:77-83.
275. Shrager P., Custer A.W., Kazarinova K., Rasband M.N., Mattson D. Nerve conduction block by nitric oxide that is mediated by the axonal environment. J. Neurophysiol. 1998, 79:529-536.
276. Siebert J.R., Osterhout D.J. The inhibitory effects of chondroitin sulfate proteoglycans on oligodendrocytes. J. Neurochem. 2011, 119:176-188.
277. Siebert J.R., Stelzner D.J., Osterhout D.J. Chondroitinase treatment following spinal contusion injury increases migration of oligodendrocyte progenitor cells. Exp. Neurol. 2011, 231:19-29.
278. Siegenthaler M.M., Tu M.K., Keirstead H.S. The extent of myelin pathology differs following contusion and transection spinal cord injury. J. Neurotrauma 2007, 24:1631-1646.
279. Sim F.J., Zhao C., Penderis J., Franklin R.J. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J. Neurosci. 2002, 22:2451-2459.
280. Skihar V., Silva C., Chojnacki A., Doring A., Stallcup W.B., Weiss S., Yong V.W. Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate. Proc. Natl. Acad. Sci. USA 2009, 106:17992-17997.
281. Skripuletz T., Miller E., Grote L., Gudi V., Pul R., Voss E., Skuljec J., Moharregh-Khiabani D., Trebst C., Stangel M. Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system. Brain Behav. Immun. 2011, 25:1592-1606.
282. Sloane J.A., Batt C., Ma Y., Harris Z.M., Trapp B., Vartanian T. Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc. Natl. Acad. Sci. USA 2010, 107:11555-11560.
283. Smith C.M., Cooksey E., Duncan I.D. Myelin loss does not lead to axonal degeneration in a long-lived model of chronic demyelination. J. Neurosci. 2013, 33:2718-2727.
284. Smith E.J., Blakemore W.F., McDonald W.I. Central remyelination restores secure conduction. Nature 1979, 280:395-396.
285. Smith P.M., Jeffery N.D. Histological and ultrastructural analysis of white matter damage after naturally-occurring spinal cord injury. Brain Pathol. 2006, 16:99-109.
286. Sofroniew M.V. Reactive astrocytes in neural repair and protection. Neuroscientist 2005, 11:400-407.
287. Song J.H., Bellail A., Tse M.C., Yong V.W., Hao C. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. J. Neurosci. 2006, 26:3299-3308.
288. Stammers A.T., Liu J., Kwon B.K. Expression of inflammatory cytokines following acute spinal cord injury in a rodent model. J. Neurosci. Res. 2012, 90:782-790.
289. Steelman A.J., Li J. Poly(I:C) promotes TNFalpha/TNFR1-dependent oligodendrocyte death in mixed glial cultures. J. Neuroinflammation 2011, 8:89.
290. Stefoski D., Davis F.A., Faut M., Schauf C.L. 4-Aminopyridine improves clinical signs in multiple sclerosis. Ann. Neurol. 1987, 21:71-77.
291. Stock C., Schilling T., Schwab A., Eder C. Lysophosphatidylcholine stimulates IL-1beta release from microglia via a P2X7 receptor-independent mechanism. J. Immunol. 2006, 177:8560-8568.
292. Stys P.K. Anoxic and ischemic injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics. J. Cereb. Blood Flow Metab. 1998, 18:2-25.
293. 2+ exchanger. J. Neurosci. 1992, 12:430-439.
294. Sullivan P.G., Krishnamurthy S., Patel S.P., Pandya J.D., Rabchevsky A.G. Temporal characterization of mitochondrial bioenergetics after spinal cord injury. J. Neurotrauma 2007, 24:991-999.
295. Sun F., Lin C.L., McTigue D., Shan X., Tovar C.A., Bresnahan J.C., Beattie M.S. Effects of axon degeneration on oligodendrocyte lineage cells: dorsal rhizotomy evokes a repair response while axon degeneration rostral to spinal contusion induces both repair and apoptosis. Glia 2010, 58:1304-1319.
296. Syed Y.A., Baer A.S., Lubec G., Hoeger H., Widhalm G., Kotter M.R. Inhibition of oligodendrocyte precursor cell differentiation by myelin-associated proteins. Neurosurg. Focus 2008, 24:E5.
297. Syed Y.A., Hand E., Mobius W., Zhao C., Hofer M., Nave K.A., Kotter M.R. Inhibition of CNS remyelination by the presence of semaphorin 3A. J. Neurosci. 2011, 31:3719-3728.
298. Takami T., Oudega M., Bates M.L., Wood P.M., Kleitman N., Bunge M.B. Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. J. Neurosci. 2002, 22:6670-6681.
299. Talbott J.F., Cao Q., Enzmann G.U., Benton R.L., Achim V., Cheng X.X., Mills M.D., Rao M.S., Whittemore S.R. Schwann cell-like differentiation by adult oligodendrocyte precursor cells following engraftment into the demyelinated spinal cord is BMP-dependent. Glia 2006, 54:147-159.
300. Talbott J.F., Loy D.N., Liu Y., Qiu M.S., Bunge M.B., Rao M.S., Whittemore S.R. Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes. Exp. Neurol. 2005, 192:11-24.
301. Targett M.P., Sussman J., Scolding N., O'Leary M.T., Compston D.A., Blakemore W.F. Failure to achieve remyelination of demyelinated rat axons following transplantation of glial cells obtained from the adult human brain. Neuropathol. Appl. Neurobiol. 1996, 22:199-206.
302. Tator C.H., Rivlin A.S., Lewis A.J., Schmoll B. Effect of triiodo-l-thyronine on axonal regeneration in the rat spinal cord after acute compression injury. J. Neurosurg. 1983, 58:406-410.
303. Tator C.H., van der Jagt R.H. The effect of exogenous thyroid hormones on functional recovery of the rat after acute spinal cord compression injury. J. Neurosurg. 1980, 53:381-384.
304. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., Miyake K., Freudenberg M., Galanos C., Simon J.C. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 2002, 195:99-111.
305. Tetzlaff W., Okon E.B., Karimi-Abdolrezaee S., Hill C.E., Sparling J.S., Plemel J.R., Plunet W.T., Tsai E.C., Baptiste D., Smithson L.J., Kawaja M.D., Fehlings M.G., Kwon B.K. A systematic review of cellular transplantation therapies for spinal cord injury. J. Neurotrauma 2011, 28:1611-1682.
306. Thorburne S.K., Juurlink B.H. Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J. Neurochem. 1996, 67:1014-1022.
307. Totoiu M.O., Keirstead H.S. Spinal cord injury is accompanied by chronic progressive demyelination. J. Comp. Neurol. 2005, 486:373-383.
308. Totoiu M.O., Nistor G.I., Lane T.E., Keirstead H.S. Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis. Exp. Neurol. 2004, 187:254-265.
309. Traka M., Arasi K., Avila R.L., Podojil J.R., Christakos A., Miller S.D., Soliven B., Popko B. A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination. Brain 2010, 133:3017-3029.
310. Trapp B.D., Stys P.K. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 2009, 8:280-291.
311. Tripathi R., McTigue D.M. Prominent oligodendrocyte genesis along the border of spinal contusion lesions. Glia 2007, 55:698-711.
312. Tripathi R.B., McTigue D.M. Chronically increased ciliary neurotrophic factor and fibroblast growth factor-2 expression after spinal contusion in rats. J. Comp. Neurol. 2008, 510:129-144.
313. Tsutsui S., Stys P.K. Metabolic injury to axons and myelin. Exp. Neurol. 2013, 246:26-34.
314. van der Bruggen M.A., Huisman H.B., Beckerman H., Bertelsmann F.W., Polman C.H., Lankhorst G.J. Randomized trial of 4-aminopyridine in patients with chronic incomplete spinal cord injury. J. Neurol. 2001, 248:665-671.
315. Vartanian T., Li Y., Zhao M., Stefansson K. Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol. Med. 1995, 1:732-743.
316. Wang X., Arcuino G., Takano T., Lin J., Peng W.G., Wan P., Li P., Xu Q., Liu Q.S., Goldman S.A., Nedergaard M. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat. Med. 2004, 10:821-827.
317. Wanner I.B., Anderson M.A., Song B., Levine J., Fernandez A., Gray-Thompson Z., Ao Y., Sofroniew M.V. Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J. Neurosci. 2013, 33:12870-12886.
318. Watanabe M., Toyama Y., Nishiyama A. Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. J. Neurosci. Res. 2002, 69:826-836.
319. Waxman S.G. Conduction in myelinated, unmyelinated, and demyelinated fibers. Arch. Neurol. 1977, 34:585-589.
320. Waxman S.G. Axonal conduction and injury in multiple sclerosis: the role of sodium channels. Nat. Rev. Neurosci. 2006, 7:932-941.
321. Whittaker M.T., Zai L.J., Lee H.J., Pajoohesh-Ganji A., Wu J., Sharp A., Wyse R., Wrathall J.R. GGF2 (Nrg1-beta3) treatment enhances NG2(+) cell response and improves functional recovery after spinal cord injury. Glia 2012, 60:281-294.
322. Wilkins A., Kondo Y., Song J., Liu S., Compston A., Black J.A., Waxman S.G., Duncan I.D. Slowly progressive axonal degeneration in a rat model of chronic, nonimmune-mediated demyelination. J. Neuropathol. Exp. Neurol. 2010, 69:1256-1269.
323. Wilson C.M., Gaber M.W., Sabek O.M., Zawaski J.A., Merchant T.E. Radiation-induced astrogliosis and blood-brain barrier damage can be abrogated using anti-TNF treatment. Int. J. Radiat. Oncol. Biol. Phys. 2009, 74:934-941.
324. Wolfe D.L., Hayes K.C., Hsieh J.T., Potter P.J. Effects of 4-aminopyridine on motor evoked potentials in patients with spinal cord injury: a double-blinded, placebo-controlled crossover trial. J. Neurotrauma 2001, 18:757-771.
325. Woodruff R.H., Fruttiger M., Richardson W.D., Franklin R.J. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol. Cell Neurosci. 2004, 25:252-262.
326. Xiao J., Wong A.W., Willingham M.M., van den Buuse M., Kilpatrick T.J., Murray S.S. Brain-derived neurotrophic factor promotes central nervous system myelination via a direct effect upon oligodendrocytes. Neurosignals 2010, 18:186-202.
327. Xiong Y., Rabchevsky A.G., Hall E.D. Role of peroxynitrite in secondary oxidative damage after spinal cord injury. J. Neurochem. 2007, 100:639-649.
328. Xu J., Kim G.M., Chen S., Yan P., Ahmed S.H., Ku G., Beckman J.S., Xu X.M., Hsu C.Y. iNOS and nitrotyrosine expression after spinal cord injury. J. Neurotrauma 2001, 18:523-532.
329. Yasuda A., Tsuji O., Shibata S., Nori S., Takano M., Kobayashi Y., Takahashi Y., Fujiyoshi K., Hara C.M., Miyawaki A., Okano H.J., Toyama Y., Nakamura M., Okano H. Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord. Stem Cells 2011, 29:1983-1994.
330. Ye F., Chen Y., Hoang T., Montgomery R.L., Zhao X.H., Bu H., Hu T., Taketo M.M., van Es J.H., Clevers H., Hsieh J., Bassel-Duby R., Olson E.N., Lu Q.R. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat. Neurosci. 2009, 12:829-838.
331. Yonezawa M., Back S.A., Gan X., Rosenberg P.A., Volpe J.J. Cystine deprivation induces oligodendroglial death: rescue by free radical scavengers and by a diffusible glial factor. J. Neurochem. 1996, 67:566-573.
332. Young K.M., Psachoulia K., Tripathi R.B., Dunn S.J., Cossell L., Attwell D., Tohyama K., Richardson W.D. Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling. Neuron 2013, 77:873-885.
333. Young W. Role of calcium in central nervous system injuries. J. Neurotrauma 1992, 9(Suppl 1):S9L 25.
334. Yuen T.J., Johnson K.R., Miron V.E., Zhao C., Quandt J., Harrisingh M.C., Swire M., Williams A., McFarland H.F., Franklin R.J., Ffrench-Constant C. Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination. Brain 2013, 136:1035-1047.
335. Zai L.J., Wrathall J.R. Cell proliferation and replacement following contusive spinal cord injury. Glia 2005, 50:247-257.
336. Zai L.J., Yoo S., Wrathall J.R. Increased growth factor expression and cell proliferation after contusive spinal cord injury. Brain Res. 2005, 1052:147-155.
337. Zambonin JL, Zhao C, Ohno N, Campbell GR, Engeham S, Ziabreva I, Schwarz N, Lee SE, Frischer JM, Turnbull DM and others. 2011. Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis. Brain 134(Pt 7):1901-13.
338. Zawadzka M., Rivers L.E., Fancy S.P., Zhao C., Tripathi R., Jamen F., Young K., Goncharevich A., Pohl H., Rizzi M., Rowitch D.H., Kessaris N., Suter U., Richardson W.D., Franklin R.J. CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell 2010, 6:578-590.
339. Zhang Y., Taveggia C., Melendez-Vasquez C., Einheber S., Raine C.S., Salzer J.L., Brosnan C.F., John G.R. Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation. J. Neurosci. 2006, 26:12174-12185.
340. Zhang Y.W., Denham J., Thies R.S. Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors. Stem Cells Dev. 2006, 15:943-952.
341. Ziv Y., Avidan H., Pluchino S., Martino G., Schwartz M. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proc. Natl. Acad. Sci. USA 2006, 103:13174-13179.